An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

This publication has 24 references indexed in Scilit:

• Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience
  Cancer, 2010
• Cell cycle control and cancer chemotherapy
  Journal of Cellular Biochemistry, 1994
• Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
  The Journal of Pathology, 1993
• Prognostic Significance of the 67-Kilodalton Laminin Receptor Expression in Human Breast Carcinomas
  JNCI Journal of the National Cancer Institute, 1993
• Treatment Results and Prognostic Factors in a Population-Based Study of Epithelial Ovarian Cancer
  Gynecologic Oncology, 1993
• Analysis of prognostic factors and survival in patients with ovarian cancer treated with second-line hexamethylmelamine (altretamine)
  Cancer Treatment Reviews, 1991
• Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
  Proceedings of the National Academy of Sciences, 1990
• A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives
  European Journal of Cancer and Clinical Oncology, 1989
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989
• Regression and recursive partition strategies in the analysis of medical survival data
  Journal of Clinical Epidemiology, 1988